Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Article Intro - Open-H to Support Foundation Models in Surgical Robotics
The Open-H-Embodiment Consortium, coordinated by NVIDIA and Johns Hopkins, released the largest open dataset of medical‑robotic video paired with synchronized kinematics. Spanning more than 49 institutions and six robot platforms—including da Vinci, Versius, and MIRA—the collection covers surgical manipulation, ultrasound, and endoscopy. Using the data, researchers built GR00T‑H, a vision‑language‑action model that achieved 64% success on a 29‑step suturing benchmark, and Cosmos‑H, a world‑model simulator that supports nine platforms from a single checkpoint. The release aims to solve the chronic data shortage hindering autonomous surgical robotics.
Review Questions Benefits of Anti-Amyloid Alzheimer’s Drugs
A Cochrane review of 17 clinical trials involving 20,342 patients with early Alzheimer’s disease found that anti‑amyloid drugs provide no clinically meaningful benefit on cognitive decline or dementia severity. The analysis also highlighted an increased risk of brain swelling and...
Sanofi Reports the CHMP Positive Opinion for Cenrifki (Tolebrutinib) to Treat Non-Relapsing SPMS
Sanofi’s oral BTK inhibitor Cenrifki (tolebrutinib) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for treating secondary progressive multiple sclerosis (SPMS) without relapses in the past two years. The recommendation is...
FDA Approves Weekly Self‑Injectable Saphnelo for Lupus
#AZN Saphnelo for treating systemic lupus erythematosus, approved by US FDA for self-administration via a once a week autoinjector Pen.
Tesaro's Breach Claim Dismissed, Jemperli Licence Fight Persists
Looks like #GSK subsidiary TESARO Inc., has had a "claim for anticipatory breach" against AnaptysBio kicked out by Delaware Chancery Court. Principal contract dispute still ongoing though around Jemperli (Dostarlimab) licence agreement.
Why “More Doctors” Won’t Fix the Provider Shortage
The United States faces a health‑care provider shortage, but adding more physicians alone won’t solve it. The article argues that regulatory and reimbursement structures limit the contributions of nurses, counselors, community health workers, and other allied professionals who are already...
AI in Single-Cell Analysis: Solving the Interpretation Gap
Single‑cell omics drives drug discovery but interpreting cell‑state annotations remains a bottleneck. Nygen Analytics introduced CyteType, an AI‑augmented platform that adds a traceable interpretation layer to existing pipelines, converting raw clusters into biologically meaningful labels. By combining marker‑gene analysis, literature...
Invest in the Future of Cancer Diagnostics and Treatment
Cancer incidence is rising as populations age and obesity increases, prompting a shift toward proactive diagnostics. Researchers are advancing liquid‑biopsy technologies, especially multi‑omics MCED tests, to detect tumors earlier and with greater specificity. Simultaneously, AI‑enhanced imaging is slashing MRI scan...
Exclusive Human Milk Diet Benefits Very Low Birth Weight Infants
A phase III randomized controlled trial in Japan demonstrated that an exclusive human milk diet markedly improves growth velocity and reduces serious complications in very low birth weight (VLBW) infants compared with mixed feeding regimens. The study eliminated bovine‑based protein fortifiers,...
Feature: Strengthening Patient Understanding Through Digital Consent and Patient Information
Radar Healthcare’s Digital Consent platform replaces paper‑based forms with regulated, electronic workflows, delivering consistent, auditable patient consent. The solution pairs with EIDO Patient Information, a standardized library endorsed by the High Court and Royal Colleges, to provide clear, multi‑language content....
Novartis’ Itvisma Receives the CHMP Positive Opinion for Spinal Muscular Atrophy
Novartis’ gene‑replacement therapy Itvisma (onasemnogene abeparvovec) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for treating patients aged two years and older with 5q spinal muscular atrophy (SMA). The recommendation is...
Disruptions in Medicare Advantage Coverage in 2026
A new study reveals that forced disenrollment from Medicare Advantage (MA) plans will spike to about 10% in 2026, affecting roughly 2.9 million beneficiaries nationwide. In Vermont, 92% of MA enrollees are already facing plan exits, the highest state concentration. The...
NIHR Innovation Programme Offers Funding for Preventative Technologies in Community Care
The NIHR Invention for Innovation Funding at the Speed of Translation (FAST) programme is offering grants of £50,000‑£100,000 (≈$62,500‑$125,000) over six to twelve months for preventative technologies in community care. The funding targets solutions that can be integrated into neighbourhood...
Smart T-Shirt Piloted at Leicester to Support Diagnosis of Breathing Pattern Disorders
A pilot in Leicester is testing Atride’s Anasa® Smart Shirt, a wearable t‑shirt that embeds nanotech sensors to continuously monitor breathing patterns. The device’s data will be benchmarked against the current gold‑standard motion‑capture photography to assess accuracy for diagnosing breathing...
Evonik: €80m for Biopharma CDMO Capacity in Slovakia
Evonik Industries is allocating roughly €80 million (about $87 million) to expand its fermentation plant in Slovenská Ľupča, Slovakia. The investment adds downstream capacity for pharmaceutical active ingredients and creates around 50 new jobs. The site, already a biotech hub producing spider‑silk protein...
Home Blood Pressure Checks Could Reduce Risks After Hypertensive Pregnancy
Researchers at Oxford found that daily home blood‑pressure monitoring combined with rapid medication adjustments improves arterial health in new mothers who experienced hypertensive pregnancies. In a trial of 220 women, those using a home monitor and app showed less arterial...
San Juan Launches ‘Ligtas Tigdas’ Drive for World Immunization Week 2026
San Juan City marked World Immunization Week 2026 by launching the “Ligtas Tigdas” drive, vaccinating roughly 250 residents with routine, HPV and tetanus‑diphtheria shots. The campaign targeted infants, Grade IV students, pregnant women and families needing catch‑up doses, and featured health‑education booths to...
What Your CD3 T Cell Engager Is Missing
CD3 T‑cell engagers have become a cornerstone of bispecific immunotherapy, linking T cells to cancer cells via the CD3 receptor. The article argues that despite their success, these molecules often provide only the primary activation signal, neglecting a critical secondary...
EClinicalWorks Launches Healow CCM Specialist Service to Automate Monthly Patient Outreach and Documentation
eClinicalWorks has launched the healow Chronic Care Management (CCM) Specialist Service, a specialist‑as‑a‑service model that embeds certified clinicians into ambulatory practice workflows. The service handles monthly outreach, prescription follow‑ups and care‑plan reviews, automatically documenting calls in the EHR for Medicare...
Turn Health Data Into Impact: Browns University's Online Master in Biostatistics & Health Data Science
Brown University has launched an online Master’s in Biostatistics with a concentration in Health Data Science, delivered through its School of Public Health and School of Professional Studies. The 20‑month, five‑semester program comprises nine courses and a capstone project that...
Swedish Clinic Finds Limited Eligibility for New Alzheimer Drugs
Preparing for the implementation of anti-amyloid therapies in Europe: Assessing real-world eligibility for lecanemab and donanemab in a Swedish memory clinic https://t.co/H3TgYvgVSk
The Cure for Death Means Billionaires Will Live Forever—And Be Rich Forever
U.S. billionaires enjoy a dramatically higher life expectancy, with 20% living past 80 compared to just 3.8% of the general population. Their longevity stems from access to premium healthcare, personal trainers, and cutting‑edge nutrition. Meanwhile, leaders like Putin and Xi...
Back to the Vax — Is the Measles Surge Testing MAHA’s Vaccine Rejectionism?
Measles cases in the United States have surged to levels not seen in decades, with the CDC reporting 1,748 infections by April 17, 2026—likely an undercount. The spike has prompted a noticeable shift among some vaccine‑hesitant parents, especially followers of...
Antibiotics for Acne: How Much Is Too Much?
Antibiotics can be effective for moderate‑to‑severe inflammatory acne, but they are intended for short‑term use. Oral agents such as doxycycline are typically limited to two or three months, while topical antibiotics may be used longer when combined with other therapies....
In the Land of the Unblind: Are Psychedelics Really Better than Antidepressants?
Recent meta‑analysis comparing psychedelic‑assisted therapy (PAT) with open‑label antidepressant trials finds no clinically important difference in depression outcomes. While early PAT studies suggested larger effects, the analysis shows that functional unblinding limits any advantage, and open‑label antidepressants marginally outperform blinded...
Multimorbidity Patterns Linked to Elderly Mortality Risk
A new BMC Geriatrics study of over 5,000 Shenzhen seniors links specific multimorbidity clusters to markedly higher mortality risk. Researchers used big‑data analytics and cluster‑analysis to identify patterns, finding that combinations of cardiovascular disease, diabetes and chronic respiratory illness produce...
Humanoid Robots Set to Transform Elder Care
ROBOTGYM Reveals the Future of Humanoid Elderly Assistance via @Robo_Tuo #Robotics #Tech #Technology #EmergingTech #TechForGood https://t.co/zjRD7hYqdC
Free Radicals Podcast (Longevity / Biotech Oriented)
Kexin Huang, the a16z‑backed founder of Pho, argues that biology is entering an "Agentic Biology" era where AI agents orchestrate research rather than merely analyze data. His Integrated Biology Environment (IBE), embodied in the Biomni platform, acts like an IDE...
Free Radicals Podcast (Longevity / Biotech Oriented)
Nathan Cheng argues that aging remains untreated due to a coordination failure rooted in cultural "deathism," despite roughly 100,000 daily deaths from age‑related diseases. He highlights a stark $5 B versus $100 B+ funding gap between longevity and cancer research, underscoring the...
SAS Forecast Shows AI Shifts to Core Infrastructure in Health and Life Sciences for 2026
SAS’s 2026 outlook declares that data and AI will graduate from experimental projects to essential infrastructure for health care and life sciences. The forecast cites harmonised data streams, quantum‑enabled models and regulatory sandboxes as catalysts for scalable, production‑grade AI deployment.
Qualifacts Unveils AI Suite and Interoperability Hub at NatCon26, Claiming 80% Faster Note‑Taking
Qualifacts demonstrated its expanded iQ AI suite at NatCon26, highlighting an 80% reduction in clinicians' note‑taking time and a new interoperability Marketplace. The rollout aims to streamline behavioral health workflows and deepen data connectivity across platforms.
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices
Murata Manufacturing has begun mass production of two new anisotropic magnetoresistance (AMR) sensors, the MRMS166R and MRMS168R. The MRMS166R achieves a record‑low average current draw of 20 nA while operating from a 1.2 V supply, and the MRMS168R provides up to 12 mA...
Current Political Climate Having 'Detrimental' Effect on Radiology Research, Survey Says
A recent survey published in Clinical Imaging finds that policies enacted by the Trump administration have created a hostile environment for radiology research. More than 70% of 176 authors from top radiology journals report that securing funding has become harder,...
427. DMSO HEALS THE BRAIN AND NERVOUS SYSTEM
A comprehensive review of dimethyl sulfoxide (DMSO) highlights its neuroprotective mechanisms, including radical scavenging, cerebral blood‑flow enhancement, and reversible blood‑brain barrier opening. Epidemiological data show a ten‑fold lower risk of young‑onset Parkinson’s disease among DMSO users, while clinical observations report...
Secretome-Mediated Antimicrobial and Immunomodulatory Activity of Lactobacillus Johnsonii Against Multidrug-Resistant Enteroaggregative Escherichia Coli
Researchers evaluated Lactobacillus johnsonii as a probiotic against a multidrug‑resistant enteroaggregative E. coli (EAEC) strain. The bacterium showed strong gastrointestinal tolerance, high auto‑aggregation (80 % at 4 h), and secretome‑driven inhibition of EAEC growth and biofilm formation, surpassing gentamicin. It also reduced...
Air Pollution Fuels Sarcopenic Obesity via Inflammation
Air pollution and muscle-fat imbalance: How PM2.5 components and ozone drive sarcopenic obesity through inflammation "This study provides novel insights into environmental triggers of SO, highlighting the need for integrated air quality policies targeting specific PM2.5 components and personalized prevention strategies...
South Korea’s MFDS Reiterates Ban on Gymnema Sylvestre, Bacopa in Supplements
South Korea’s Ministry of Food and Drug Safety (MFDS) has reaffirmed its ban on several botanicals and pharmaceutical compounds, including Gymnema sylvestre and Bacopa, after finding them in 18 of 30 overseas‑made health supplements sold via Amazon, eBay and other...
Children and Adolescents From Socioeconomically Disadvantaged Areas Face Barriers to Accessing Mental Health Services
Researchers at the University of Nottingham published a longitudinal analysis of the STADIA trial, tracking 1,225 children referred to England's child and adolescent mental health services (CAMHS). The study found that youths from the most socio‑economically deprived neighborhoods were significantly...
Why Some Hospitals Are Betting on Midstream Health to Help Eliminate Waste
Midstream Health, a San Francisco AI startup founded in 2023, helps hospitals slash expenses by consolidating fragmented financial and operational data. Its platform uncovers missed rebates, prevents over‑paying for supplies, and streamlines contract verification. Major systems such as Mount Sinai,...
Mapping Genomic Landscape of Multiple Myeloma Precursors
Genomic landscape of multiple myeloma and its precursor conditions [May 21, 2025] Jean-Baptiste Alberge et al. @IrenemGhobrial @NatureGenet https://t.co/DDWGRrpI4Y #mmsm #PrecisionMedicine #cagenome https://t.co/X0OPLHNkdG
Multiple Myeloma Evades GPRC5D T‑Cell Engagers via Multim
Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma [Jan 15, 2026] @hollyleeYJ et al. @NBahlis @NatureMedicine https://t.co/mz393mPMAq #mmsm #PrecisionMedicine #tcellrx THREAD: https://t.co/lNX9b7LsnR HT @AuclairDan https://t.co/d0JNE6pb5x
WHO Launches 2026 World No Tobacco Day Campaign to Curb Youth Nicotine Addiction
The World Health Organization unveiled its 2026 World No Tobacco Day campaign, focusing on nicotine addiction among adolescents. The initiative spotlights a 14.3% e‑cigarette use rate among European teens and stark policy gaps that leave youth vulnerable.
Approach to Unexplained Cytopenia in Clinical Practice
How I manage patients with unexplained cytopenia [Apr 10, 2025] Malcovati & Cazzola @BloodPortfolio https://t.co/bfCmp1AJ4R #camoldx #PrecisionMedicine https://t.co/LpQhp9W79v
Morning Headlines 4/27/26
HIStalk’s morning briefing highlighted several disparate issues: the ethical and legal pitfalls of paying informants, noting that funds rarely reach the target organization; the success of an anti‑hate nonprofit that financed undercover operatives to dismantle KKK cells; a critique of...
Weight Loss Reverses Heart Muscle Weakness in Obese HFpEF Patients, Johns Hopkins Study Finds
Researchers at Johns Hopkins Medicine reported that significant weight loss restores contractile function in heart muscle cells of severely obese patients with heart failure with preserved ejection fraction (HFpEF). The findings, published in Science, suggest body‑composition changes can directly reverse...
Amazon Launches GLP‑1 Weight‑Loss Program, Targeting $100 B Market
Amazon announced a GLP‑1‑focused weight‑management program through its One Medical platform, letting patients order injectable and oral GLP‑1 drugs with same‑day delivery. The move pits the tech giant against pharma leaders Eli Lilly and Novo Nordisk as the market races toward a...
SPI Digital Health’s Phare Health Joins R1 RCM, Expanding AI‑Driven Billing Solutions
SPI Digital Health’s Phare Health, a revenue cycle management automation startup, has been acquired by R1 RCM, the $9 billion‑valued RCM provider. The deal, whose terms were not disclosed, follows Phare Health’s $2.5 million pre‑seed raise two years ago and will embed...
Abbott Elevates Jenil Sheth to Head of Marketing, Boosting Healthcare Brand Strategy
Abbott has promoted Jenil Sheth to Head of Marketing, tasking him with steering brand and growth programs across its therapeutic and consumer health portfolios. Sheth brings more than eight years at Abbott and a deep pharmaceutical background, positioning the company...
Uridine Shields Neurons by Activating Mitochondrial K⁺ Channel
The Protective Effect of Uridine in a Rotenone-Induced Model of Parkinson’s Disease: The Role of the Mitochondrial ATP-Dependent Potassium Channel https://t.co/jBlSlgedWo
MIT Unveils Injectable “Mini‑liver” Constructs to Bridge Transplant Waitlist
MIT scientists have engineered injectable hydrogel microsphere “mini‑livers” that sustain liver function in animal models for over two months, aiming to reduce dependence on donor organs. The breakthrough, published in Cell Biomaterials, could reshape treatment for thousands on transplant waiting...